Baystate Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Baystate Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$9	Hold	16	–	–	﹤0.01%	1320
2023 Q3	$11	Hold	16	–	–	﹤0.01%	1025
2023 Q2	$53	Sell	16 -1	-6%	-$3	﹤0.01%	1037
2023 Q1	$152	Buy	+17	New	+$241	﹤0.01%	1008

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baystate Wealth Management's VBIV Position: Q4 2023 in Review

Baystate Wealth Management held its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) position steady in Q4 2023 at 16 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Baystate Wealth Management first reported a position in VBIV in Q1 2023 and has held it in 4 quarters since. The position peaked at $152 in Q1 2023. 39 funds tracked by Wall St. Rank hold VBIV as of Q4 2023.

Baystate Wealth Management held 16 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $9 as of Q4 2023.
Baystate Wealth Management left its VBI Vaccines, Inc. New Common Stock (Canada) share count unchanged in Q4 2023.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1320 holding.
Baystate Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2023 and has held it in 4 quarters since.
Baystate Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $152 in Q1 2023.
39 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.